Fundz

BioMarin Pharmaceutical Inc. Appoints Greg Friberg, M.D. as EVP, Chief Research & Development Officer and James Sabry, M.D., Ph.D. as EVP, Chief Business Officer

PUBLIC · BMRNAug 21, 2024

Position

Vice President

Company

BioMarin Pharmaceutical

James Sabry
james.sabry@bmrn.com
San RafaelBiotechnologyHealth CareMedicalGeneticsTherapeutics

Description

BioMarin Pharmaceutical Inc. has announced the appointments of Greg Friberg, M.D. as Executive Vice President, Chief Research & Development Officer, succeeding Hank Fuchs, M.D., and James Sabry, M.D., Ph.D

Quick answer

BioMarin Pharmaceutical Inc. Appoints Greg Friberg, M.D. as EVP, Chief Research & Development Officer and James Sabry, M.D., Ph.D. as EVP, Chief Business Officer (August 21, 2024). BioMarin Pharmaceutical is based in San Rafael, California, United States.

Who is the new Vice President at BioMarin Pharmaceutical?
BioMarin Pharmaceutical named James Sabry Vice President, announced August 21, 2024.
What did BioMarin Pharmaceutical announce on August 21, 2024?
BioMarin Pharmaceutical Inc. has announced the appointments of Greg Friberg, M.D. as Executive Vice President, Chief Research & Development Officer, succeeding Hank Fuchs, M.D., and James Sabry, M.D., Ph.D
What does BioMarin Pharmaceutical do?
BioMarin is a global biotechnology company founded in 1997, dedicated to transforming lives through genetic discovery.
Where is BioMarin Pharmaceutical based?
BioMarin Pharmaceutical is based in San Rafael, California, United States.
Which similar companies made leadership changes around the same time?
Novocure (September 3, 2024), NYU Langone Health (September 6, 2024), AAVantgarde Bio (September 9, 2024) and Tivic (September 13, 2024) also announced leadership changes within 45 days of BioMarin Pharmaceutical.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Genetics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at BioMarin Pharmaceutical, and when

A new leader at BioMarin Pharmaceutical brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day BioMarin Pharmaceutical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioMarin Pharmaceutical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioMarin Pharmaceutical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioMarin Pharmaceutical

Location

San Rafael, California, United States

About

BioMarin is a global biotechnology company founded in 1997, dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of genetic conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioMarin Pharmaceutical changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Claudia
Senior decision-maker at this company
••••••••@••••••••

See Claudia's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for BioMarin Pharmaceutical's next move

Learn about Strategic plan

BioMarin Pharmaceutical changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.